Carbon monoxide diffusing capacity and mortality in pulmonary arterial hypertension

Journal of Heart and Lung Transplantation

Volumn 29, Issue 2, 2010, Pages 181-187

  Chandra, Sonal ^a   Shah, Sanjiv J ^b   Thenappan, Thenappan ^a   Archer, Stephen L ^a   Rich, Stuart ^a   Gomberg Maitland, Mardi ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

carbon monoxide diffusing capacity (DLCO); pulmonary arterial hypertension; survival

Indexed keywords

CARBON MONOXIDE;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; DIAGNOSTIC VALUE; FEMALE; HUMAN; LUNG DIFFUSION CAPACITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; SURVIVAL;

ADULT; AGED; BIOLOGICAL MARKERS; CARBON MONOXIDE; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PULMONARY DIFFUSING CAPACITY; SEVERITY OF ILLNESS INDEX;

EID: 74849091604     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.07.005     Document Type: Article

References (40)

1. Farber H.W., and Loscalzo J. Pulmonary arterial hypertension. N Engl J Med 351 (2004) 1655-1665
2. Humbert M., Sitbon O., and Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 351 (2004) 1425-1436
3. Badesch D.B., Abman S.H., Simonneau G., et al. Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines. Chest 131 (2007) 1917-1928
4. D'Alonzo G.E., Barst R.J., Ayres S.M., et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 115 (1991) 343-349
5. Archer S., and Rich S. Primary pulmonary hypertension: a vascular biology and translational research "Work in progress.". Circulation 102 (2000) 2781-2791
6. Michelakis E.D. Spatio-temporal diversity of apoptosis within the vascular wall in pulmonary arterial hypertension: heterogeneous BMP signaling may have therapeutic implications. Circ Res 98 (2006) 172-175
7. Single breath carbon monoxide diffusing capacity transfer factor. Recommendations for a standard technique. Statement of the American Thoracic Society. Am Rev Respir Dis 136 (1987) 1299-1307
8. American Thoracic Society. Single-breath carbon monoxide diffusing capacity transfer factor. Recommendations for a standard technique-1995 update. Am J Respir Crit Care Med 152 (1995) 2185-2198
9. National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med 345 (2001) 1075-1083
10. Brunelli A., Xiume F., Refai M., et al. Evaluation of expiratory volume, diffusion capacity, and exercise tolerance following major lung resection: a prospective follow-up analysis. Chest 131 (2007) 141-147
11. Hadeli K.O., Siegel E.M., Sherrill D.L., et al. Predictors of oxygen desaturation during submaximal exercise in 8,000 patients. Chest 120 (2001) 88-92
12. Make B., Miller A., Epler G., et al. Single breath diffusing capacity in the industrial setting. Chest 82 (1982) 351-356
13. 2, maximum work rate, and walking distance in patients with emphysema. Chest 123 (2003) 1394-1400
14. Owens G.R., Rogers R.M., Pennock B.E., et al. The diffusing capacity as a predictor of arterial oxygen desaturation during exercise in patients with chronic obstructive pulmonary disease. N Engl J Med 310 (1984) 1218-1221
15. Rogers R.M., Coxson H.O., Sciurba F.C., et al. Preoperative severity of emphysema predictive of improvement after lung volume reduction surgery: use of CT morphometry. Chest 118 (2000) 1240-1247
16. Hamada K., Nagai S., Tanaka S., et al. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest 131 (2007) 650-656
17. Kawut S.M., Taichman D.B., Archer-Chicko C.L., et al. Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest 123 (2003) 344-350
18. Rich S., Dantzker D.R., Ayres S.M., et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 107 (1987) 216-223
19. Thenappan T., Shah S.J., Rich S., et al. A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J 30 (2007) 1103-1110
20. Patterson J.A., Naughton J., Pietras R.J., et al. Treadmill exercise in assessment of the functional capacity of patients with cardiac disease. Am J Cardiol 30 (1972) 757-762
21. Gomberg-Maitland M., Huo D., Benza R.L., et al. Creation of a model comparing 6-minute walk test to metabolic equivalent in evaluating treatment effects in pulmonary arterial hypertension. J Heart Lung Transplant 26 (2007) 732-738
22. Mogulkoc N., Brutsche M.H., Bishop P.W., et al. Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation. Am J Respir Crit Care Med 164 (2001) 103-108
23. Nathan S.D., Shlobin O.A., Ahmad S., et al. Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. Chest 131 (2007) 657-663
24. Miyamoto S., Nagaya N., Satoh T., et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 161 (2000) 487-492
25. Souza R., Jardim C., Julio Cesar F.C., et al. NT-proBNP as a tool to stratify disease severity in pulmonary arterial hypertension. Respir Med 101 (2007) 69-75
26. Chin K.M., Channick R.N., Kim N.H., et al. Central venous blood oxygen saturation monitoring in patients with chronic pulmonary arterial hypertension treated with continuous IV epoprostenol: correlation with measurements of hemodynamics and plasma brain natriuretic peptide levels. Chest 132 (2007) 786-792
27. Das S.R., Drazner M.H., Dries D.L., et al. Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study. Circulation 112 (2005) 2163-2168
28. Goetze J.P., Christoffersen C., Perko M., et al. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J 17 (2003) 1105-1107
29. Leuchte H.H., El N.M., Tuerpe J.C., et al. N-terminal pro-brain natriuretic peptide and renal insufficiency as predictors of mortality in pulmonary hypertension. Chest 131 (2007) 402-409
30. Ndrepepa G., Braun S., Schomig A., et al. Accuracy of N-terminal pro-brain natriuretic peptide to predict mortality in various subsets of patients with coronary artery disease. Am J Cardiol 100 (2007) 575-578
31. Redfield M.M., Rodeheffer R.J., Jacobsen S.J., et al. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 40 (2002) 976-982
32. Forfia P.R., Fisher M.R., Mathai S.C., et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med 174 (2006) 1034-1041
33. Blyth K.G., Groenning B.A., Martin T.N., et al. Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension. Eur Heart J 26 (2005) 1993-1999
34. Gan C.T., Lankhaar J.W., Westerhof N., et al. Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension. Chest 132 (2007) 1906-1912
35. van Wolferen S.A., Marcus J.T., Boonstra A., et al. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart 28 (2007) 1250-1257
36. Humbert M., Sitbon O., Chaouat A., et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 173 (2006) 1023-1030
37. Jensen R.L., Teeter J.G., England R.D., et al. Instrument accuracy and reproducibility in measurements of pulmonary function. Chest 132 (2007) 388-395
38. Jensen R.L., Teeter J.G., England R.D., et al. Sources of long-term variability in measurements of lung function: implications for interpretation and clinical trial design. Chest 132 (2007) 396-402
39. Wanger J., and Irvin C. Comparability of pulmonary function results from 13 laboratories in a metropolitan area. Respir Care 36 (1991) 1375-1382
40. Wise R.A., Teeter J.G., Jensen R.L., et al. Standardization of the single-breath diffusing capacity in a multicenter clinical trial. Chest 132 (2007) 1191-1197